<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-ZMB-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Zambia: Targeted country assistance</narrative>
   <narrative xml:lang="FR">Zambie (la): Aide cibl&#xE9;e aux pays</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.21107.35" role="4">
   <narrative xml:lang="EN">Johns Hopkins University</narrative>
  </participating-org>
  <participating-org ref="US-EIN-84-0399006" role="4" type="21">
   <narrative xml:lang="EN">The Aspen Institute</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Zambia</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41114" role="4" type="40">
   <narrative xml:lang="EN">United Nations Development Projects (UNDP)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="ZM" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="ZM" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Lusaka</narrative>
   </name>
   <administrative code="ZM" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-15.40809 28.28636</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1322906</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1638366</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1358899</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2314</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="ZMBPEF-TCA-ASPEN2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">258827</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">22500</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-CIDRZ2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">383730</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-JHU2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">185516</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">19193</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">232740</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">220401</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-ASPEN2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">442239</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-CIDRZ2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">119294</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-JHU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">322727</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-UNDP2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">114331</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNDP (United Nations Development Projects (UNDP))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Development Projects (UNDP)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">9000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">341874</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">288900</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-ASPEN2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">75326</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-CIDRZ2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">614929</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-JHU2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">90000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-UNDP2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">163330</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNDP (United Nations Development Projects (UNDP))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Development Projects (UNDP)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">21663</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">154440</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">239211</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="ZMBPEF-TCA-CIDRZ2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">2314</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001034">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">94603</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001200">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">54056</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001331">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-148659</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-42921</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">42921</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000220">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">215905</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002602">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-25"></transaction-date>
   <value currency="USD" value-date="2020-08-25">121393</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-215905</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">215905</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-36580</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-58582</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">36580</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">58582</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005575">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">72536</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000168">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">-72536</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000836">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-02"></transaction-date>
   <value currency="USD" value-date="2021-03-02">72536</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004943">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-17"></transaction-date>
   <value currency="USD" value-date="2021-11-17">72536</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000923">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">22500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001033">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">173496</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-23697</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001330">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-123132</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000622">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-28"></transaction-date>
   <value currency="USD" value-date="2019-11-28">34738</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000624">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-28"></transaction-date>
   <value currency="USD" value-date="2019-11-28">36933</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000621">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-28"></transaction-date>
   <value currency="USD" value-date="2019-11-28">66748</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-28"></transaction-date>
   <value currency="USD" value-date="2019-11-28">99312</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000015">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-16"></transaction-date>
   <value currency="USD" value-date="2020-01-16">44498</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000397">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-18"></transaction-date>
   <value currency="USD" value-date="2020-02-18">73866</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-118364</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">118364</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002837">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-22"></transaction-date>
   <value currency="USD" value-date="2021-06-22">12420</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003477">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-27"></transaction-date>
   <value currency="USD" value-date="2021-07-27">12420</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003478">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-27"></transaction-date>
   <value currency="USD" value-date="2021-07-27">325</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003476">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-27"></transaction-date>
   <value currency="USD" value-date="2021-07-27">91357</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004947">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">49220</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-17"></transaction-date>
   <value currency="USD" value-date="2021-12-17">15173</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-17"></transaction-date>
   <value currency="USD" value-date="2021-12-17">39487</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006613">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">146666</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">247536</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CIDRZ (CIDRZ Direct Funding)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CIDRZ Direct Funding</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">112271</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001268">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">73245</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001711">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-05"></transaction-date>
   <value currency="USD" value-date="2020-05-05">184609</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001154">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">138117</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">7146</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001310">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">12047</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003870">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-17"></transaction-date>
   <value currency="USD" value-date="2021-08-17">114331</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNDP (United Nations Development Projects (UNDP))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Projects (UNDP)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006613">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">48999</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNDP (United Nations Development Projects (UNDP))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Projects (UNDP)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-3663</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">3663</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">2963</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">1500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">4648</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000924">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">232740</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">219618</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">122256</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">154440</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000925">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">220401</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">214000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">74900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">239211</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-zambia-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Zambia 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zambia-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Zambia 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-zambia-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Zambia 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zambia-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Zambia 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-zambia-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Zambia 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zambia-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Zambia 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zambia-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Zambia 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-zambia-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Zambia 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-ZMB" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="AEFI Surveillance: To strengthen immunisation&#xA0;&#xA0;AEFI Surveillance&#xA0;system through Orientation of selected health workers from both public and private sector in AEFI surveillance and reporting">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">AEFI surveillance has been from inception a week link in the Immunisation program. However, in the recent few year the country has reported some improvement in reporting of AEFI indicators. 2021 performance has demonstrated significant improvement though much still requires improvement. Through integration with the COVID-19 vaccination, there has much achieved. More than 600 cases of AEFIs have been reported with greater majority being associated to COVID-19 vaccines. 
AEFI focal point persons have been nominated at district and provincial level and 3-day trainings conducted for two provinces through virtual platforms. 
AEFI guidelines and monitoring tools including investigation form as have printed and disseminated to subnational levels.
Investigations have started though at a slow pace 
Causality assessments have started with two meeting held and a third one scheduled before the end of the year.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data: 

1. Conduct Data Quality Review to improve data use for decision-making at National and Selected sub-national level

2. Conduct Data Quality Review to improve data use for decision-making at selected health facilities in selected districts">
      <location ref="ZM"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">While this activity is critical, MOH at national level ME has proposed to defer the activity to next year as their staff at the various levels are engaged in other activities</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CIDRZ : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Provide support to receive and inspect all vaccine and safe injection shipments according to shipment schedule with timely and accurate reporting
-Timely, accurate quantification for UNICEF forecasting
-Timely, accurate quantification for NVS application</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.	Skills transfer of immunisation forecasting, receipt and reporting">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">All shipments have been cleared and reported timely. UNICEF forecasting for 2021 was completed in September 2021, and submission of NVS renewal will take place in May 2022. Stockouts at national and sub-national levels have been reported for Rota, BCG, Penta. Rota was said to be stocked out at the health facility level as well.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Desk review for immunisation financing conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="6.	Improve immunisation financing transparency and advocacy">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">This activity is planned for 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CIDRZ : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Development of Logistimo + Vaccine management SOPs and tools</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.2 Vaccine management/ Logistimo SOP and tools review and development">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">An advanced second version of the Effective Vaccine Management Manual has been developed and circulated for review but is waiting for final sign off by MOH for printing which is anticipated to take place in early July.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.2 Vaccine management/ Logistimo SOP and tools review and development">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The SOP has been finalised and is waiting to be printed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support for EPI activities, including the development, finalisation and submission of key EPI documents and reports.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4.1 Provide technical support for EPI planning, implementation.">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">CIDRZ is supporting the Ministry in COVID-19 vaccine activities, including the COVID-19 vaccine introduction orientation in all 10 provinces. CIDRZ further supported MOH in the development of the COVID-19 supervisory plan and supervisory checklist and to date, 2 supportive supervisory activities have been supported by CIDRZ. 
CIDRZ supported MOH in reviewing HPV registers and microplans from all districts in readiness for the HPV vaccination. Additional support was provided to conduct HPV data collection orientation in 5 provinces, as well as pre-data collection and intra campaign monitoring of all eligible girls in 5 provinces.
CIDRZ further supported MOH in developing the Child Health package that integrated mOPV mop-up, HPV vaccination and COVID-19 vaccination tool.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">6 quarterly NITAG Meetings conducted and evidence-based recommendations in place, and timely, accurate meeting minutes</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.1 Conduct quarterly NITAG meetings to improve EPI policy and programme decision-making">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">During the period under review, 2 ZITAG COVID-19 Technical working group meetings were conducted. The objective of the first meeting was to review evidence, safety and efficacy and recommendations for the COVID-19 vaccine on pregnancy and lactating mothers. This evaluation was conducted on Pfizer, AstraZeneca and Johnson &amp; Johnson vaccines. ZITAG recommendations were presented to the MOH for the development of new guidelines. Another ZITAG met to recommend programmatic considerations to deploy different types of COVID-19 vaccines available. Those reviewed were Sputnik V, Sinopharm, Moderna and Sinovac. A summary of the recommendation was presented to the MOH, which equally form part of the COVID-19 vaccine National Vaccine Deployment Plan (NVDP). CIDRZ provided support to both meetings by developing the Terms of References, recommendation framework, meeting proceeding and updating/finalisation of the framework recommendation notes, and as well as financial support, but the funding of the meeting was through the COVAX TA.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Provide support to receive and inspect all vaccine and safe injection shipments according to shipment schedule with timely and accurate reporting
Timely, accurate quantification for UNICEF forecasting
Timely, accurate quantification for NVS Application</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.1 Support the skills transfer of immunisation forecasting, receipt and reporting.">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">During the period under review, a total of 18 vaccine shipments were received. Regulatory permits were obtained for all vaccine shipments and processes. The shipments included Oral Cholera Vaccine pre-emptive for the campaign in cholera hotspots and COVID-19 vaccines for the pandemic. Vaccine Arrival Reports (VARs) were submitted within 72 hours for routine vaccines. All quantities of vaccines were received according to the shipment notification.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Initiate/support EPI-OPT in Southern/Western province</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.1 EPI-OPT support">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">Through PEF support, CIDRZ has continued to support the Government and working with CHAZ, PATH and the UNICEF to initiate EPI-OPT in Western Province and continue to support in Southern Province. EPI-OPT aims to improve health care worker knowledge and skills, improve EPI data, and increase demand for immunisations from the community level to attain accurate and improved equitable coverage rates. 
CIDRZ with government and partners supported the training on Logistimo, the supply chain software, to at the health facility level in Western and Sothern Provinces. The implementation of Logistimo aims to strengthen the cold chain and vaccine logistics at all levels, some of which are; integrated services, remote management, logistics ordering management, monitoring the status of the cold chain through the GSM enabled temperature sensor and many others. CIDRZ supported 115 tablets for use at these health facilities. 
CIDRZ has continued to support the MOH?s implementation of EPI-OPT in Southern Province by strengthening the immunisation supply chain, working with districts to deliver vaccines to 311 health facilities in the province every month. In March, 279 out of the targeted 289 health facilities were reached,4 were cut off, and their requirements were left at the nearest health facility while the rest had adequate stock. A total of 99,791 doses of vaccines were delivered. In April, 276 health facilities were reached, providing a total of 138,374 doses of vaccines. In May, 281 health facilities were accessed, delivering a total of 104,545 doses. The total count for June is currently being tabulated.
CIDRZ further supported the quarterly data review meeting in Southern and Western Province, which took place from 26-28 April 2021 and 2-5 June 2021, respectively. In addition, CIDRZ supported MOH to conduct the data review and Technical Supportive Supervision (TSS) from 29 April to 5 May in Southern Province and from 7-11 June 2021 Western Province.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Sub-national mentorship/support for Child health week, PIE</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.2 Sub-national monitoring/support for key EPI activities">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of districts uising scorecards</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build national capacity to train and support district level DHIS2 users in use of Scorecard and BNA apps and follow up technical assistance">
      <location ref="ZM"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">Due to delayed completion of the primary activities (Install and configure BNA, Action Tracker &amp; Scorecards applications for DHIS2 &amp; pilot the use of the applications at national level) by UiO, UNICEF was unable to carry out training of districts as capacity building in use of Scorecard and BNA apps.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Progress and final report submitted and satisfactory</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to Gov&apos;t to conduct EVM 2.0">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">EVM2 has been fully implemented. The report is currently under finalization and will be submitted by end Q4 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to Gov&apos;t for implementation of key EPI interventions including identification and monitoring of zero dose children, and supply chain strengthening (CCEOP, EVM2.0)">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">Technical support was fully provided to MoH for implementation of the EPI program. Interventions supported included continuation of services, strengthening of the iSCM, as well as support for demand related activities in selected low performing districts. CCEOP and EVM2 activities initiated in Q1 were fully implemented and supported by end Q3. Reports are under finalization and will be submitted by end Q4 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Urban Immunisation situation analysis report finalised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Unreached children in urban areas (Increased numbers of unreached children in urban areas year after year) - Conduct Assessment of the urban immunisation situation">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">In order to gain understanding on the factors affecting access to immunisation services in the urban setting, a situational analysis is underway. A concept note has been finalised. work on the drafting protocols for the fieldwork are ongoing as well as finalisation of the accompanying budget. The expert skills including anthropologist identified to work with the field team to ensure key community factors are brought out and inform recommendations. However, the processes are currently slowed down in view of the ongoing third wave of the COVID-19 pandemic in the country. Field work is anticipated as soon as the situation wanes down in the third quarter of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">90% targeted population vaccinated with second dose of HPV</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen capacity for country in HPV planning, preparation and implementation of activities for the introduction of HPV vaccine">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">Following the submission and approval of the Zambia HPV Introduction proposal in 2017, the Ministry of Health implemented several activities in planning, preparation and implementation of activities. These activities were implemented three years ago and reported on at that time. The uptake of second dose of HPV has not reached 90% in the last year due to various reasons including the closure of schools dues COVID-19 public health restrictions
1. Capacity built to deliver quality HPV vaccination services through provision of guidelines for all districts and health facilities providing immunisation services in the country. WHO led the processes of drafting, reviewing and finalisation of HPV guidelines for health workers to guide safe and quality delivery. 
2. Additionally, WHO capacitated a team of 60 central, provincial level as well as selected staff from Lusaka district (capital) for HPV trainers to role out HPV vaccinations in their respective districts as a key facilitator in the trainings.
3. WHO capacitated the monitoring of HPV vaccinations at all levels through the adaptation, review and finalisation of monitoring tools which included HPV vaccination registers, summary sheets and vaccination cards. These templates were disseminated to all facilities during trainings.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Concept note on Urban Immunisation situation analysis finalised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Unreached children in urban areas (Increased numbers of unreached children in urban areas year after year) - Conduct Assessment of the urban immunisation situation">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">In order to reduce urban inequities in accessing immunisation services, and to develop targeted evidence based focused attention on underserved urban slums and squatter settlements, WHO has led the drafting concept concept note (Draft concept is in place) that seeks to understand low access to health services as well as to seek improvement of urban immunization programmes using all opportunities to vaccinate eligible children and mothers. The progress made so far in conducting the analysis is the identification of field team and roadmap for the activity including co-opting anthropologists to assist in the finalisation of tools and protocols to be used that shall assess both community as well as health system factors affecting accessing immunisation services in urban setting. It is anticipated that this activity shall be conducted in the third quarter of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Improved MCV2 coverage and reduced MCV1-2 Drop out rate in targeted districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Planning and Implementation of strategies to improve uptake of second year of life interventions in selected facilities in two districts to improve MCV2 performance: Updating of existing supervisory and screening tools; Development of 2YL Job Aids Orientation of EPI staff in 2YL interventions in 50% of targeted Health facilities">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The Ministry of Health selected one district to be targeted for implementation of Second Year of Life (2YL) interventions in 2 sub-districts in Lusaka District. The objective of 2YL in the district was to increase MCV2 coverage by 20% by end of 2020 from 60% to 80%. WHO provided technical and financial 
MCV2 coverage for Lusaka district was 81.4% from 2019 coverage of 60%. 
WHO provided technical and financial support for the implementation of selected key interventions for 2YL. 1. Health workers and community health workers were capacitated to implement 2YL in two targeted low performing sub-districts in Lusaka district which have very large populations. 
2. Increased community awareness on the importance of completing immunisation schedule with the second dose of measles facilitated by the development, printing of IEC materials and messages used by sensitised community health workers 
3. Capacity built for utilisation of immunisation data including identification of population immunity gaps to inform strategies for reaching communities
4. Professional bodies ( Nurses) to be advocate for Immunisations in their various assignments
The above interventions contributed to the improvement of coverage in the district as a whole despite the many challenges faced in the district which included COVID-19 which resulted in the deployment of staff for the national COVID-19 response, gassing in communities which also disrupted service delivery</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitoring of strategies to improve uptake of second year of life interventions in two districts to improve MCV2: Monthly supervision of EPI Staff in targeted Health Facilities using revised tools Implementation of 10% inteventions in 2019 DQIP plan">
      <location ref="ZM"></location>
     </target>
     <actual value="Completed">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">This activity is an extension of the above milestone. As reported 
The Ministry of Health selected one district to be targeted for implementation of Second Year of Life (2YL) interventions in 2 sub-districts in Lusaka District. The objective of 2YL in the district was to increase MCV2 coverage by 20% by end of 2020 from 60% to 80%. WHO provided technical and financial 
MCV2 coverage for Lusaka district was 81.4% from 2019 coverage of 60%. 
WHO provided technical and financial support for the implementation of selected key interventions for 2YL. 1. Health workers and community health workers were capacitated to deliver 2YL interventions in two targeted low performing sub-districts in Lusaka district which have very large populations. 
2. Health workers were capacitated to conduct review of immunisation data including identification of population immunity gaps to inform strategies for reaching communities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CIDRZ : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">-Support national M&amp;E TWG for HMIS data analysis
-Aid in identification of where zero dose children are located and liaise with service delivery subcommittee to develop strategies to reach children
-Aid in the identification of hard to reach populations (gender related)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5.	To improve data use for decision-making">
      <location ref="ZM"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The project is active in the weekly M&amp;E TWG though much focus has been on COVID-19 vaccination. CIDRZ supported 
COVID-19 data management trainings conducted under COVAX TA.
CIDRZ is hiring an M&amp;E coordinator to be seconded to EPI to assist in RI as well as COVID-19 vaccination data as there are gaps in current analysis.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CIDRZ : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2 NITAG meetings conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Improve EPI policy and programme decision-making through NITAG meetings">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">One ZITAG meeting took place during the period, but it was supported by COVAX TA. The objective of the meeting was to recommend the maximum quantity of COVID-19 vaccine stock at a time. Additionally, ZITAG recommended priority groups for the Pfizer vaccine. 
CIDRZ supported this meeting by developing the Terms of References, recommendation framework, meeting proceedings and updating/finalisation of the framework recommendation notes, and financial support.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">-Support EPI TWG and sub committees to monitor EPI performance and services developed and in use including support for campaigns/introduction + tools development
-Support Full Portfolio planning process and development of all documents</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="7.	Support for national EPI planning and oversight">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The project is supporting the EPI TWG and all subcommittees. Activities during the period include the development 
of a COVID-19 microplanning tool, vaccine management SOPs, and SOPs/training materials for Pfizer and Moderna. Additionally the project is supporting the development of the next CDS proposal and updates to the NDVS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Subnational support and mentorship for key EPI activities
? Support COVID-19 vaccine rounds 
? Support Child health week &amp; routine immunisation strengthening activities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4. Capacity building to strengthen routine immunisation at sub-national level">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The project supported 2 districts in COVID-19 immunisation microplanning and 51 districts for outreach and Advocacy, Communication and Social Mobilisation (ACSM) in the recent COVID-19 vaccination campaign.
Additionally, the project supported supportive supervision for Child Health week in two provinces.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strategic recommendations for informing EPI programming for next cMYP available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Comprehensive EPI programme review">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">In line WHO recommendations for conducting EPI review, the country planned for this activity for Q3-4. With minor delays the activity is currently underway with ongoing data analysis and report writing. The report shall completed before the end of the year. The expected outcome is the recommendations to inform the next strategic planning cycle for immunisation program for the next five years</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Comprehensive EPI programme review">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The recommendations await the finalisation of Comprehensive EPI review that has been delayed. A costed concept note finalised, lead consultant for the comprehensive EPI review engaged. Activity deferred with restrictions of meetings due to onset of third wave and sharp rise in COVID-19 cases in the last few weeks. The activity shall be implemented by end of Q3.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Comprehensive EPI programme review">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The recommendations await the finalisation of Comprehensive EPI review that has been delayed. A costed concept note finalised, lead consultant for the comprehensive EPI review engaged. Activity deferred with restrictions of meetings due to onset of third wave and sharp rise in COVID-19 cases in the last few weeks. The activity shall be implemented by end of Q3.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">KAP study conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct research to determine social and behavioral drivers of immunization uptake; Develop evidence-based communication plan">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">There was a minor delay to implement this activity as the EPI team was stretched with other ongoing activities as well as addressing the immediate Covid-19 priorities (vaccine introduction) in Q2. During Q4 however, it was agreed to integrate the KAP study into the existing ToR for a planned Covid-19 vaccination KAP study. Follow up action includes contracting the identified consultancy firm to conduct both studies.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Urban Immunisation: 

1. Develop Context-specific plan addressing bottlenecks of in Situational Analysis for selected district

2. Support Implementation of feasible context-specific strategies and activities supporting Urban Immunisation in selected district">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The country planned to develop a context specific interventions informed by situational analysis conducted on Urban Immunisation. The concept note for Urban immunisation to be conducted in Lusaka district was developed and the protocol for implementing the assessment was finalised. A consultant to support this work was also engaged. The next steps for this activity is to conduct field assessment for the activity. 
The delay of implementation of the activity was related to the fact that this assessment has to take place in the community wit communities and other stakeholders at community level. The third was of the COVID-19n pademic did not spare the activity with travel restrictions that wee implemented to limit spread as well as the limitation on in-person meeting, The activity target high population urban slums of the capital city of the country. The Situational analysis is in process and should be completed by mid December, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap for improved integration of EPI with other PHC services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Comprehensive Mutli Year Plan: 

1. Conduct Workshop for Prioritisation and development of strategies informed by EPI Review recommendations 

2. Conduct Workshop for Alignment with global/ regional strategies/targets; Activities &amp; M/E framework">
      <location ref="ZM"></location>
     </target>
     <actual value="Major Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">The sector&apos;s National Health Strategic plan comes to an end this year as does the Immunisation Multi year plan. In the 2021 TCA, the program planned to conduct the workshop for the prioritisation ad development of strategies informed by EPI review recommendations as well as conducting the workshop for alignment with global and regional strategies and targets such as the recent Immunisation Agenda 2030. Due to the COVID-19 Pandemic and pubic health measures through travel restrictions and in-person meetings. 
MOH EPI recommended that the EPI review be conducted to include field visits. With this background, the EPI review was conducted in fourth quarter of 2021. Data analysis is being done with a draft report with recommendations to be ready in the next two weeks. 
Other challenges faced include the urgency for government and all partners to implement activities that were deferred from second and third quarter when the country was faced with the third wave of the COVID-19 pandemic which was the most severe of the three waves the country has experienced. This is against a background of the very lean MOH EPI struct at HQ to cover all pending activities that were deferred to the end of the year.
The meetings shall</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and mechanisms to assess and monitor quality and acceptance of services developed and in use by countries</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support Immunisation work related to new vaccine introduction (Proposal development, capacity building ( development/review training plans, development/adaptation of operational guidelines for health care workers; developement of policy guidelines; adaptation of training materials; support implementation of and documenting readiness assessment; adaptation of tools for monitoring and supervision; 
2. Data improvement - review and analysis of data to inform strategies and targeted; povide technical support for capacity for sub-national data review meetings in selected districts/provinces, support review of technical updates and reports for dissemination; 
3. Support the drafting of reports including JRFs, Provide technical support for the implementation/ data analysis/ interpretation of findings of Post Introduction vaccine and other evaluations including coverage survey. Support integrated Immunisation Support Supervision and on-site capacity OJT and documentation using the open data kit platform.">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">Through the WHO TCA WHO has achieve the following:
1.	New vaccine introduction - The country provided technical leadership and guidance for the acquisition of COVID-19 vaccine for support to technical processes required including:
a.	Vaccine request form; development of Zambia National Vaccine Deployment Strategy, coordinating activities to ensure readiness vaccine readiness tool (VIRAT/VIRAF) at national level as well as supporting the updating Terms of references for new and existing subcommittees
b.	Adaptation of COVID-19 Vaccination operational guidelines and the subsequent updating to include newer vaccine candidates; training modules for health worker and training plans; integrated supervision and mentorship following introduction of vaccines; adaptation of readiness checklists.
c.	Led vaccination introduction trainings as assigned by MOH.
2.	Provided technical assistance in the development of policy guidelines for the continuity of immunisations as part of the essential services, technical guidance for the development of COVD -19 vaccination in special population groups for health workers 
3.	Review &amp; Data improvement - review and analysis of data to inform strategies and targeted to identify low performing districts requiring support from national level culminating if mobilisation of financial resources targets for these districts. The concept note for the support to improve capacity for sub-national data review meetings and activity is pending. WHO was technical lead support for coordination of the drafting of the eJRF as well as the monthly COVID-19 JRF; implementation/ data analysis/ interpretation of Post Introduction vaccine and Measles Rubella coverage survey with drafting of report in process. Supported development of concept note and tools for urban immunisation and post SIA coverage survey. 
4.	Supported integrated Immunisation Support Supervision and on-site capacity OJT and documentation using the open data kit platform in selected provinces.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft in service and pre service HMIS Training module developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To support implementation of selected Data quality interventions for improving quality of data&#xA0; - Implementation of Annual Desk Review of&#xA0; selected prioritised&#xA0;&#xA0;&#xA0; inteventions in DQIP plan&#xA0; - Concept note for Preservice HMIS Training module and finalised">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">To improve data quality, the Ministry of Health with support from partners embarked on a delivery approach for institutionalization of this HMIS curriculum in nursing. The new curriculum is being developed with new elements for pedagogical and delivery innovations. 
Series of processes and activities with involvement of various stakeholders have been undertaken and progress to date are as follows: 
- Assessment of the existing pre-service curricula 
- Establishment of stakeholder engagement with the General Nursing Council, selected colleges and the Zambia National Public Health Council
- Establishment and formalization of a Sub-committee under the M&amp;E Technical Working Group, called ?People sub-committee? with membership from various institutions and clear roadmap of activities for the curriculum development process
- Pre-service curriculum framework developed and presented for endorsement to the GNC and M&amp;E TWG respectively
- Draft content curriculum materials developed
WHO specific task in this process is a tail end task of providing technical expertise to review of the draft HMIS pre-service materials developed; develop HMIS module presentations, exercises and media tools and develop a manual for lecturers. WHO&apos;s role was affected by the rate of implementation of the pre-cursor activities. Engagement with MOH is underway to move on to the WHO specific roles through available safe platforms to develop, review and finalise the nurses pre-service HMIS curriculum in the next quarter.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">United Nations Development Programme : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Progress reports on 1. Plans and Budgets 2.Navision 3.Fixed Assets Reconciliation 4.Knowledge management 5.Risk registers 6.Quarterly assurance and compliance reviews at HQ &amp; Districts 7.Financial mentorship visits and coaching</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Carry out systems analysis at central level in grant and project management. The assessment will look at critical and specific tasks that would enhance and accelerate project implementation.
Develop a skills transfer plan to address the gaps identified in the systems assessment.
Conduct a results-based management training (RBM) for staff at Finance and EPI Unit at Ministry of Health. )
Exchange of skills and knowledge conducted through periodic coaching and exchange visits">
      <location ref="ZM"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">Complete</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Carry out systems analysis at central level in grant and project management. The assessment will look at critical and specific tasks that would enhance and accelerate project implementation. Develop a skills transfer plan to address the gaps identified in the systems assessment. Conduct a results-based management training (RBM) for staff at Finance and EPI Unit at Ministry of Health. ) Exchange of skills and knowledge conducted through periodic coaching and exchange visits">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Carry out systems analysis at central level in grant and project management. The assessment will look at critical and specific tasks that would enhance and accelerate project implementation.
Develop a skills transfer plan to address the gaps identified in the systems assessment.
Conduct a results-based management training (RBM) for staff at Finance and EPI Unit at Ministry of Health. )
Exchange of skills and knowledge conducted through periodic coaching and exchange visits">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CIDRZ : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of Health Facilities with Improved vaccine management practices (Baseline = 0)

50% of Health Facilities with use of Logistimo 
(289 Southern; 273 Western/ Baseline = 0)

-80% of Health Facilities with improved full stock availability
 (289 Southern; 273 Western/ Baseline = 67%)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3.	Strengthen supply chain sustainability &amp; Logistimo use/EPI-OPT transition">
      <location ref="ZM"></location>
     </target>
     <actual value="On Track">
      <location ref="ZM"></location>
      <comment>
       <narrative xml:lang="EN">80% of Health Facilities (HF) with improved vaccine management defined as: Average of below is 77%
?	71% of HFs with improved vaccine wastage (90% Southern/52% Western)
?	78% Frig temp monitor: 68% Southern /85% Western)
?	81% of HFs without VVM3/4 (91% Southern &amp; 70% for Western)
59% of HFs utilising Logistimo (87% Southern/27% Western)
58% of HFs with improved full stock availability (57% Southern/59% Western). During the period, national stock-outs were experienced in rotavirus, IPV, BCG and Penta.
Additionally, the EPI-OPT transition plan has been developed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Development of Logistimo + Vaccine management SOPs and tools Timely, accurate quantification for UNICEF forecasting</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2.2 Vaccine management/ Logistimo SOP and tools review and development">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Aspen Management Partners : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implemented recommendations from assessment, including but not limited to project planning tools, time management tools, etc</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct assessment of EPI team and develop implementation plan to improve skills and processes where gaps exist">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct assessment of EPI team and develop implementation plan to improve skills and processes where gaps exist">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Optimized TWG and coordination structures in place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct assessment of TWGs and other coordination structures and develop plans to improve and enhance">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct assessment of TWGs and other coordination structures and develop plans to improve and enhance">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct assessment of TWGs and other coordination structures and develop plans to improve and enhance">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implemented recommendations from assessment, including but not limit to refreshed schedule of meetings, minutes template, document review process, etc.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct assessment of TWGs and other coordination structures and develop plans to improve and enhance">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct assessment of TWGs and other coordination structures and develop plans to improve and enhance">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Optimized tools and processes for supportive supervision in place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review current sub-national supervision structures and develop improved processes and tools">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review current sub-national supervision structures and develop improved processes and tools">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review current sub-national supervision structures and develop improved processes and tools">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Implemented recommendations from assessment, including but not limited to enhanced supervision tools and processes.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review current sub-national supervision structures and develop improved processes and tools">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Review current sub-national supervision structures and develop improved processes and tools">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo - Zambia : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Jhpiego : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on field operations of survey</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MOH to implement Post MR SIA coverage survey">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on MOH NIP application of lessons to reach zero dose children and take up other findings on life course vaccination and equitable coverage.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support to Gov&apos;t for implementation of key EPI interventions including application of findings from Post SIA coverage survey">
      <location ref="ZM"></location>
     </target>
     <actual>
      <location ref="ZM"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
